Enanta Pharmaceuticals, Inc. (ENTA)
USD 5.85
(-4.57%)
USD 5.85
(-4.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 79.2 Million | 86.16 Million | 97.07 Million | 122.47 Million | 205.19 Million | 206.62 Million |
| Cost of Revenue | - | 2.97 Million | - | - | - | - |
| Gross Profit | 79.2 Million | 83.18 Million | 97.07 Million | 122.47 Million | 205.19 Million | 206.62 Million |
| Operating Expenses | 216.41 Million | 210 Million | 206.64 Million | 164.11 Million | 168.45 Million | 118.29 Million |
| Selling, General and Administrative Expenses | 52.88 Million | 45.48 Million | 32.53 Million | 27.35 Million | 26.24 Million | 23.44 Million |
| Research and Development Expenses | 163.52 Million | 164.52 Million | 174.11 Million | 136.75 Million | 142.21 Million | 94.85 Million |
| Other Expenses | - | 83 Thousand | 1.99 Million | 6.62 Million | 8.81 Million | 4.79 Million |
| Cost and Expenses | 216.41 Million | 210 Million | 206.64 Million | 164.11 Million | 168.45 Million | 118.29 Million |
| Operating Income | -137.2 Million | -123.84 Million | -109.57 Million | -41.63 Million | 36.73 Million | 88.32 Million |
| Interest Expense | 5.14 Million | 1.57 Million | - | - | 8.81 Million | 4.85 Million |
| Income Tax Expense | 2.82 Million | -433 Thousand | -28.58 Million | 1.14 Million | -826 Thousand | 21.16 Million |
| Earnings before Tax | -130.99 Million | -122.18 Million | -107.57 Million | -35.01 Million | 45.55 Million | 93.12 Million |
| Net Income | -133.81 Million | -121.75 Million | -78.99 Million | -36.16 Million | 46.38 Million | 71.95 Million |
| Earnings Per Share Basic | -6.38 | -5.91 | -3.92 | -1.81 | 2.37 | 3.48 |
| Earnings Per Share Diluted | -6.38 | -5.91 | -3.92 | -1.81 | 2.21 | 3.48 |
| Weighted Average Shares Outstanding | 20.96 Million | 20.6 Million | 20.17 Million | 19.94 Million | 19.58 Million | 20.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.96 Million | 20.6 Million | 20.17 Million | 19.94 Million | 20.96 Million | 20.65 Million |
| Gross Margin | 1.00 | 0.97 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -1.56 | -1.40 | -1.13 | -0.34 | 0.18 | 0.43 |
| Profit Margin | -1.69 | -1.41 | -0.81 | -0.30 | 0.23 | 0.35 |
| EBITDA | -123.47 Million | -119.21 Million | -104.24 Million | -37.99 Million | 39.99 Million | 90.84 Million |
| Earnings Before Tax Margin | -1.73 | -1.44 | -1.13 | -0.34 | 0.18 | 0.43 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 17.97 Million | 17.05 Million | 18 Million | 18.93 Million | 79.2 Million | 18.89 Million |
| Cost of Revenue | 594 Thousand | 621 Thousand | 642 Thousand | 669 Thousand | 2.37 Million | 651 Thousand |
| Gross Profit | 17.37 Million | 16.43 Million | 17.36 Million | 18.26 Million | 76.83 Million | 18.24 Million |
| Operating Expenses | 41.56 Million | 49.82 Million | 52.88 Million | 49.96 Million | 216.41 Million | 55.6 Million |
| Selling, General and Administrative Expenses | 12.82 Million | 14.23 Million | 16.51 Million | 13.79 Million | - | 12.61 Million |
| Research and Development Expenses | 28.74 Million | 35.58 Million | 36.37 Million | 36.16 Million | - | 42.98 Million |
| Other Expenses | - | - | - | -4.69 Million | - | 1.86 Million |
| Cost and Expenses | 42.15 Million | 49.82 Million | 52.88 Million | 49.96 Million | 216.41 Million | 55.6 Million |
| Operating Income | -24.18 Million | -32.76 Million | -34.88 Million | -31.03 Million | -137.2 Million | -36.71 Million |
| Interest Expense | 2.35 Million | -2.56 Million | 3.44 Million | 3.15 Million | 5.14 Million | -1.99 Million |
| Income Tax Expense | -395 Thousand | -363 Thousand | -622 Thousand | -1.41 Million | 2.82 Million | 4.22 Million |
| Earnings before Tax | -23.05 Million | -31.52 Million | -34.02 Million | -29.51 Million | -130.99 Million | -34.84 Million |
| Net Income | -22.65 Million | -31.15 Million | -33.4 Million | -28.1 Million | -133.81 Million | -39.06 Million |
| Earnings Per Share Basic | -1.07 | -1.47 | -1.58 | -1.33 | - | -1.86 |
| Earnings Per Share Diluted | -1.07 | -1.47 | -1.58 | -1.33 | - | -1.86 |
| Weighted Average Shares Outstanding | 21.18 Million | 21.16 Million | 21.08 Million | 21.05 Million | 20.96 Million | 21.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.18 Million | 21.16 Million | 21.08 Million | 21.05 Million | 20.96 Million | 21.05 Million |
| Gross Margin | 0.97 | 0.96 | 0.96 | 0.96 | 0.97 | 0.97 |
| EBIT Margin | -1.31 | -1.92 | -1.66 | -1.36 | - | -1.94 |
| Profit Margin | -1.26 | -1.83 | -1.86 | -1.48 | -1.69 | -2.07 |
| EBITDA | -23.59 Million | -32.76 Million | -29.94 Million | -25.69 Million | - | -36.71 Million |
| Earnings Before Tax Margin | -1.35 | -1.92 | -1.94 | -1.64 | -1.73 | -1.94 |
6626
RGLD
CHJTF
300154
3826
PMNT